Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

URL of this page:

VPS13B gene

vacuolar protein sorting 13 homolog B

Normal Function

Researchers are still working to determine the exact role of the VPS13B gene (also called the COH1 gene) in the human body. Studies show that the protein produced from this gene is a part of the Golgi apparatus, which is a cell structure in which newly produced proteins are modified so they can carry out their functions. In particular, the VPS13B protein is involved in a modification called glycosylation, which is the attachment of sugar molecules to proteins. The VPS13B protein also appears to be involved in the sorting and transporting of proteins inside the cell.

Studies suggest several functions for the VPS13B protein in the body. The protein appears to play an important role in the normal growth and development of nerve cells (neurons). It may also be involved in the growth and development of adipocytes, which are cells that store fats for energy, and may play a role in the storage and distribution of fats in the body.

Health Conditions Related to Genetic Changes

Cohen syndrome

More than 150 different mutations in the VPS13B gene have been found in individuals with Cohen syndrome. Individuals with this condition typically have intellectual disability, eye problems, and distinctive facial features. Another common feature of the condition is obesity, particularly around the torso but not the arms and legs (truncal obesity). Most of the mutations that cause Cohen syndrome result in a premature stop signal in the instructions for making the VPS13B protein. Researchers believe that this genetic change leads to the production of an abnormally short, nonfunctional version of the protein. Studies suggest that a loss of this protein's function disrupts the organization of the Golgi apparatus and impairs normal glycosylation. However, it is not known how the absence of functional VPS13B protein or these cellular changes lead to the signs and symptoms of Cohen syndrome. Researchers speculate that problems with neuron development underlie intellectual disability, eye problems and other features of Cohen syndrome. Abnormal fat storage may cause truncal obesity in people with the condition.

In the Finnish population, 75 percent of individuals with Cohen syndrome have a mutation in both copies of the VPS13B gene that deletes two DNA building blocks (base pairs). This mutation is sometimes written as 3348_3349delCT. The deletion causes a premature stop signal in the instructions for making the VPS13B protein.

Two common mutations occur in the Old Order Amish population. The first mutation adds one base pair and is sometimes written as 9258_9259insT. This mutation creates a premature stop signal in the instructions for making the VPS13B protein. The second mutation changes a single protein building block (amino acid) in the VPS13B protein. Specifically, this mutation replaces the amino acid isoleucine with the amino acid threonine at position 2820 (written as Ile2820Thr or I2820T). Outside the Finnish and Amish populations, nearly all mutations in the VPS13B gene occur in only one or a small number of families.

More About This Health Condition

Other Names for This Gene

  • CHS1
  • COH1
  • Cohen syndrome 1
  • DKFZp313I0811
  • KIAA0532
  • vacuolar protein sorting 13 homolog B (yeast)
  • vacuolar protein sorting 13B

Additional Information & Resources

Tests Listed in the Genetic Testing Registry

Scientific Articles on PubMed

Catalog of Genes and Diseases from OMIM

Gene and Variant Databases


  • Duplomb L, Duvet S, Picot D, Jego G, El Chehadeh-Djebbar S, Marle N, Gigot N, Aral B, Carmignac V, Thevenon J, Lopez E, Riviere JB, Klein A, Philippe C, Droin N, Blair E, Girodon F, Donadieu J, Bellanne-Chantelot C, Delva L, Michalski JC, Solary E, Faivre L, Foulquier F, Thauvin-Robinet C. Cohen syndrome is associated with major glycosylation defects. Hum Mol Genet. 2014 May 1;23(9):2391-9. doi: 10.1093/hmg/ddt630. Epub 2013 Dec 13. Citation on PubMed
  • Falk MJ, Feiler HS, Neilson DE, Maxwell K, Lee JV, Segall SK, Robin NH, Wilhelmsen KC, Traskelin AL, Kolehmainen J, Lehesjoki AE, Wiznitzer M, Warman ML. Cohen syndrome in the Ohio Amish. Am J Med Genet A. 2004 Jul 1;128A(1):23-8. doi: 10.1002/ajmg.a.30033. Citation on PubMed
  • Kolehmainen J, Black GC, Saarinen A, Chandler K, Clayton-Smith J, Traskelin AL, Perveen R, Kivitie-Kallio S, Norio R, Warburg M, Fryns JP, de la Chapelle A, Lehesjoki AE. Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport. Am J Hum Genet. 2003 Jun;72(6):1359-69. doi: 10.1086/375454. Epub 2003 May 2. Citation on PubMed or Free article on PubMed Central
  • Limoge F, Faivre L, Gautier T, Petit JM, Gautier E, Masson D, Jego G, El Chehadeh-Djebbar S, Marle N, Carmignac V, Deckert V, Brindisi MC, Edery P, Ghoumid J, Blair E, Lagrost L, Thauvin-Robinet C, Duplomb L. Insulin response dysregulation explains abnormal fat storage and increased risk of diabetes mellitus type 2 in Cohen Syndrome. Hum Mol Genet. 2015 Dec 1;24(23):6603-13. doi: 10.1093/hmg/ddv366. Epub 2015 Sep 10. Citation on PubMed
  • Seifert W, Holder-Espinasse M, Spranger S, Hoeltzenbein M, Rossier E, Dollfus H, Lacombe D, Verloes A, Chrzanowska KH, Maegawa GH, Chitayat D, Kotzot D, Huhle D, Meinecke P, Albrecht B, Mathijssen I, Leheup B, Raile K, Hennies HC, Horn D. Mutational spectrum of COH1 and clinical heterogeneity in Cohen syndrome. J Med Genet. 2006 May;43(5):e22. doi: 10.1136/jmg.2005.039867. Citation on PubMed or Free article on PubMed Central
  • Seifert W, Kuhnisch J, Maritzen T, Horn D, Haucke V, Hennies HC. Cohen syndrome-associated protein, COH1, is a novel, giant Golgi matrix protein required for Golgi integrity. J Biol Chem. 2011 Oct 28;286(43):37665-75. doi: 10.1074/jbc.M111.267971. Epub 2011 Aug 24. Citation on PubMed or Free article on PubMed Central
  • Seifert W, Kuhnisch J, Maritzen T, Lommatzsch S, Hennies HC, Bachmann S, Horn D, Haucke V. Cohen syndrome-associated protein COH1 physically and functionally interacts with the small GTPase RAB6 at the Golgi complex and directs neurite outgrowth. J Biol Chem. 2015 Feb 6;290(6):3349-58. doi: 10.1074/jbc.M114.608174. Epub 2014 Dec 9. Citation on PubMed or Free article on PubMed Central
  • Wang H, Falk MJ, Wensel C, Traboulsi EI. Cohen Syndrome. 2006 Aug 29 [updated 2016 Jul 21]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. Available from Citation on PubMed

The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.